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Scaffolding proteins add a new layer of complexity to the dynamics of cell signaling.
Above their basic function to bring several components of a signaling pathway together,
recent experimental research has found that scaffolds influence signaling in a much more
complex way: scaffolds can exert some catalytic function, influence signaling by allosteric
mechanisms, are feedback-regulated, localize signaling activity to distinct regions of the
cell or increase pathway fidelity. Here we review experimental and theoretical approaches
that address the function of two MAPK scaffolds, Ste5, a scaffold of the yeast mating
pathway and KSR1/2, a scaffold of the classical mammalian MAPK signaling pathway.
For the yeast scaffold Ste5, detailed mechanistic models have been valuable for the
understanding of its function. For scaffolds in mammalian signaling, however, models
have been rather generic and sketchy. For example, these models predicted narrow
optimal scaffold concentrations, but when revisiting these models by assuming typical
concentrations, rather a range of scaffold levels optimally supports signaling. Thus, more
realistic models are needed to understand the role of scaffolds in mammalian signal
transduction, which opens a big opportunity for systems biology.
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INTRODUCTION
The three-tiered MAPK signaling cascade is a highly con-
served signaling pathway that regulates the cellular response
to a variety of external stimuli in all eukaryotes. A diverse
range of receptors initiates this pathway, which consists of a
phosphorylation-dependent relay of protein activation, resulting
in altered transcription, ultimately regulating processes such as
cell proliferation and differentiation. The details of this signaling
pathway are very well studied and detailed maps of the function
of specific protein kinases and protein phosphatases within the
pathway have been produced (Oda et al., 2005). However, in
recent years it became clear that a number of scaffold proteins
play an essential role in the regulation of this signaling network.
Scaffold proteins are defined by the binding of at least two
members of a signaling cascade (Chuderland and Seger, 2005;
Oda et al., 2005). These scaffolds bring together and organize
components of the cascade to facilitate MAPK activation.
The proteins that act as scaffolds include KSR1/2, IQGAP1,
β-arrestin 1/2, MORG1, MP1, and paxillin in mammalian
systems [see Table 1 for an overview, and the website of Rony
Seger (http://www.weizmann.ac.il/Biological_Regulation/New
Files/rony/scaffolds.pdf) for a comprehensive list of scaffolds].
While most systems-biological research into the path-
way neglected the presence of the scaffolds, in recent years
many detailed mechanistic studies have been conducted
that shed light on the function of these proteins. Besides
their main function of assembling complexes, scaffolds are
thought to minimize crosstalk with other signaling cascades
(Dhanasekaran et al., 2007) and likewise mediate crosstalk
(Kolch, 2005), protect kinases from phosphatases (Perlson
et al., 2006) and target signals to a specific subcellular location
(Roskoski, 2012).
Most insights in the function of scaffolds on MAPK signaling
have been obtained in studies of MAPK signaling in yeast, where
the function of the scaffold Ste5 is well understood. In mam-
mals, the most intensively researched scaffolds are the KSR family
members. Within this paper, we will thus focus on describing the
different implications of these two scaffolds on the dynamics of
the signaling systems, and will revisit mathematical models that
have been utilized to study the function of scaffolds in general in
the light of data on MAPK signaling.
Ste5 AND KSR—TWO SCAFFOLDS FOR MAPK SIGNALING
WITH NO SEQUENCE SIMILARITY
Evidence for scaffold proteins in MAPK first came from stud-
ies within the budding yeast S. Cerevisiae. These investigations
showed that Ste5 is critically important for the mating path-
way in yeast as mutation of Ste5 resulted in a lack of response
to pheromone (Choi et al., 1994; Marcus et al., 1994). Ste5
is involved in assembling the three-tiered cascade consisting of
MAP3K Ste11, MAP2K Ste7, MAPK Fus3 through cooperative
binding (Flatauer et al., 2005). Although the Ste5 protein in
yeast and the KSR protein family in mammalian cells share sim-
ilar functions as scaffold they lack any sequence similarity. KSR,
Kinase Suppressor of Ras, was originally identified as a regulator
of Ras following genetic screens in D. melanogaster and C. elegans
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Table 1 | Overview of scaffolds for MAPK signaling in mammalian cells and their functions and locations.
Scaffold Comments
KSR1 and 2
Kinase Suppressor of Ras: KSR is bound to MEK in the cytoplasm. Upon Ras activation, KSR translocates with MEK1/2 to the
plasma membrane, which brings MEK1/2 in close proximity to its activator C-Raf and downstream effectors of ERK1/2. These
interactions result in the formation of the Raf/MEK/ERK complex (Raman et al., 2007).
β-arrestin 1 and 2
β-arrestins are abundant in clathrin coated pits and enhance MAPK signaling by scaffolding C-Raf, MEK, and ERK (DeFea et al.,
2000; Shenoy and Lefkowitz, 2011). The β-arrestins act in a similar way to Sef by directing the MAPK signaling to the cytosol
and preventing the translocation of ERK to the nucleus.
Paxillin
Located at focal adhesions, alongside other focal adhesion-specific proteins such as Focal Adehsion Kinase (FAK) and
actopaxin (Brown and Turner, 2004). Focal adhesions are sites of tight adhesion between the actin cytoskeleton and the
extracellular matrix and are regions of signal transduction that relate to growth control. The coordinated assembly and
disassembly of protein complexes allows for cytoskeletal remodeling and thus enables cell motility. Paxillin plays a major role
within this process by regulating cell spreading and migration (Turner, 2000). Paxillin is constitutively bound to MEK at the
focal adhesions and in response to hepatocyte growth factor binds MEK and ERK and then binds FAK which promotes the
activation of phosphatidylinositol-3kinase (PI3K) and Rac (King et al., 1998).
MP1
MEK Partner-1/MPKS1 Mitogen-activated protein kinase scaffold 1 MP1 selectively binds to MEK1 and ERK1, but not MEK2 or
EKR2 (Schaeffer et al., 1998). By bringing MEK1 and ERK1 in close proximity to one another, MP1 enhances signaling through
this pathway. This complex is targeted to late endosomes by the interaction of MP1 with the endosome protein p14 and
enhances the MAPK signaling toward this compartment (Wunderlich et al., 2001). Down-regulation of MP1 or p14 expression
reduced ERK/MAPK activation, whereas over-expression increased ERK/MAPK signaling (Teis et al., 2002). Furthermore, the
increased ERK activation was dependent on the localization of the scaffold complex to the late endosomes as mislocalization
of MP1 caused damping of the duration of the MAPK signal. The MP1-p14 scaffold also interacts with PAK1 and results in
enhanced phosphorylation and activation of MEK during cell adhesion and spreading on fibronectin (Pullikuth et al., 2005). In
addition, MP1 also interacts with MORG1.
MORG1
MAPK organizer MORG1 binds C-Raf, MEK, ERK, and MP1. MORG1 behaves according to the prozone effect. Interestingly,
stimulation of cells with serum or lysophosphatidic acid enhanced ERK activity whereas stimulation with EGF did not
(Vomastek et al., 2004).
Shoc2/Sur 8
A leucine rich repeat protein which forms a complex with Raf and Ras. Initial studies have shown that when over-expressed,
mammalian Shoc2/Sur 8 enhances Raf activation by promoting its interaction with Ras and thus enhancing the strength of
ERK signaling (Li et al., 2000). Strikingly, inhibition of Shoc2/Sur8 causes inhibition of MAPK in tumor cells with mutant Ras
(Rodriguez-Viciana et al., 2006).
IQGAP1
Binds B-Raf, MEK, and ERK and facilities ERK activation at specific levels of EGF or insulin-like growth factor, which shows
that optimal ERK/MAPK activation requires a balanced stoichiometry of the IQGAP1 to signaling proteins (Roy et al., 2004).
IQAGP1 is over-expressed in some cancers such as breast and ovarian, therefore its scaffolding functions for the ERK pathway
may contribute significantly to tumorigenesis (Jadeski et al., 2008).
PEB1
Phosphatidyl-ethanolamine-binding protein 1/RKIP binds to both Raf and MEK and prevents their physical interaction, inhibiting
MEK phosphorylation, and activation by C-Raf and B-Raf (Yeung et al., 1999; Park et al., 2005). Following mitogenic
stimulation, RKIP dissociates from Raf to allow MEK activation. RKIP induces switch like behavior of MEK (Shin et al., 2009). It
has been demonstrated that RKIP protein expression is down-regulated in various metastatic cancer cells (Granovsky and
Rosner, 2008) and is associated with cancer cells becoming resistant to chemotherapy (Keller, 2004; Chatterjee et al., 2004).
Sef
Sef is located at the Golgi apparatus and binds to activated MEK and facilitates activation of ERK. Sef acts as a spatial regulator
for MAPK signaling by preventing ERK translocation to the nucleus but retaining it in the cytoplasm. (Torii et al., 2004).
(Kornfeld et al., 1995; Sundaram and Han, 1995; Therrien et al.,
1995). Mammalian genomes and C. elegans have two isoforms,
KSR1 and KSR2.
KSR proteins contain five conserved domains, CA1 to CA5.
CA1, which is an N-terminal 40-residue region unique to KSR
proteins and CA2, a proline rich region, are of unknown func-
tion. CA3 is a cysteine rich zinc finger domain, and is essential
for membrane localization following activation of the pathway
and similar to the corresponding domain found in Raf (Michaud
et al., 1997; Zhou et al., 2002). CA4 is a serine/threonine rich
region that serves as a binding site for ERK and is also similar
to the analogous position in Raf, except that it does not contain a
Ras binding domain found in Raf. Located at the C-terminal end
is the CA5 putative kinase domain that binds to Raf and MEK
and is also closely related to that region in Raf. Because subdo-
main II of CA5 lacks a catalytic lysine thought to be important
for kinase function of the domain (Therrien et al., 1995), there has
been much speculation as whether these kinases were catalytically
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inert. However, in 2011 KSR was shown to have some catalytic
activity toward MEK (Brennan et al., 2011; Hu et al., 2011).
KSR interacts with, B-Raf, C-Raf, MEK1/2, and ERK1/2 coor-
dinating the assembly of these components into a multiprotein
complex (Therrien et al., 1996; McKay et al., 2009). In resting
cells, MEK1/2 is constitutively bound to KSR1 in the cytosol (Yu
et al., 1998), see also Figure 1A. In addition, regulatory 14-3-3
proteins are also bound to KSR at two phosphoserine residues
(S297 and S392) and these play a role in localizing KSR in the
cytoplasm (Müller et al., 2001). Upon stimulation of the cell,
S392 is dephosphorylated by protein phosphatase-2A (PP2A)
(Ory et al., 2003), which releases 14-3-3 proteins and allows KSR
to re-localize to the cell membrane (Figure 1B), similarly to how
14-3-3 regulate the cellular location of the Raf proteins (Jaumot
and Hancock, 2001). Once at the cell membrane, KSR interacts
with Raf, which is facilitated by the protein connector enhancer of
RAS1 (CNKSR1). An effector of KSR1 is the kinase CK2 (casein
kinase 2) which has been shown to bind to the scaffold and
to maximally enhance growth factor-induced phosphorylation
of B-Raf and C-Raf (Ritt et al., 2007). Once Raf is activated,
it in turn phosphorylates and activates MEK. At the same time
ERK1/2 is recruited and phosphorylated. Subsequently, activated
ERK1/2 is released and translocated to the cytoplasm or the
nucleus (Figure 1B). It has been shown that both KSR1 and B-Raf
are feedback phosphorylation targets of ERK and that this pro-
cess is enhanced by the docking of activated ERK (McKay et al.,
2009). Consequently, the signaling complex is disrupted and thus
signaling via ERK is terminated.
Similar to KSR, Ste5 relocalizes to the membrane upon stimu-
lation by a mechanism that is described in the following and visu-
alized in Figure 1C. Receptor activation by pheromone binding is
relayed to a trimeric G-protein, which releases its βγ-subunit as a
consequence. Gβγ consists of Ste18, which sits at the membrane
due to its lipid anchor, and Ste4, which directly interacts with
several downstream effectors. Ste4 interacts with Ste20, a p-21
activated protein kinase (PAK) which is itself recruited to the
membrane and activated by binding to Rho-like G protein Cdc42.
However, Ste4 also binds to the Ste5-Ste11 complex and thus
fulfils the task of making Ste11 accessible to phosphorylation by
Ste20. Furthermore, Ste5 undergoes some conformational change
that leads to oligomerization of the scaffold (Feng et al., 1998;
Wang and Elion, 2003; Bhattacharyya et al., 2006). Once Ste11
is active, the signal is transmitted to the scaffold bound kinases
Ste7 and Fus3. It has been shown that phosphorylation of Ste7
and ultimately Fus3 strictly requires membrane localization of
Ste5, Ste5 binding to Gβγ and the self-interaction of the scaf-
fold Ste5 (Pryciak and Huntress, 1998; Maeder et al., 2007).
While there is in general only a weak interaction of Ste5 and
Fus3, artificial dimerization of Ste5 stimulated the association
of Fus3 (Slaughter et al., 2007). Ste5 also allosterically stimu-
lates the autophosphorylation of Fus3 on Tyr182. Fus3 on the
other hand feedback-phosphorylates Ste5, which downregulates
pathway output by an unknown mechanism (Oda et al., 2005;
Bhattacharyya et al., 2006). For a more detailed description of the
pathway we refer the reader to the review by Bardwell (2004).
IMPROVED SIGNALING PERFORMANCE BY THE ACTION OF
SCAFFOLDS
How does the presence of scaffolds change the fidelity of sig-
naling? When kinases are bound to scaffold proteins their local
concentration is increased. Consequently, targets of the kinases
do experience higher kinase concentrations when bound to the
same scaffold and thus their interactions are re-enforced (Park
et al., 2003; Lamson et al., 2006). For example, activation of MEK
is increased by ∼10-fold upon KSR1 expression (McKay et al.,
2009). Due to the increased contact between kinases and their
A B C
FIGURE 1 | The role of scaffolds KSR and Ste5 in MAPK signaling.
(A) In quiescent cells an inactive KSR/MEK complex exists in the cytosol.
(B) Upon stimulation of the cell, KSR translocates to the cell membrane
and forms an active complex with phosphorylated Raf, MEK, ERK.
Activated ERK detaches from the scaffold with three outcomes; (1) ERK
dimerizes in the cytoplasm where the dimer remains or translocates to the
nucleus; (2) ERK translocates to the nucleus; (3) KSR acts as a platform
where ERK dimers are assembled and the new complex can interact with
substrates in the cytoplasm. (C) Schematic of the yeast mating
pheromone response pathway.
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substrates, scaffolds are primarily thought to enable signaling,
or be positive regulators of signaling. Especially weaker signals
are believed to be transduced only in the presence of scaffolds,
as dynamic relocalization of the scaffold from the cytoplasm to
the receptor at the membrane increases the chance of success-
ful signal initiation (Harding et al., 2005). Additionally it has
been proposed that scaffolds might protect kinases from dephos-
phorylation whilst they are bound in the complex (Levchenko
et al., 2000). This might be because the phosphatases are freely
diffusing and thus are present inmuch lower local concentrations,
or phosphatases might be sterically hindered, though this has not
been shown experimentally yet.
Another way in which scaffolds can contribute positively to
signal transmission is by acting as allosteric stimulators. An exper-
imental study in Drosphilia Schneider S2 cells observed that the
overexpression of KSR increased the amount of active Raf (Udell
et al., 2011). KSR allosterically activated the kinase domain of
Raf in direct proportion with KSR concentration. How is that
possible? The intricate mechanism by which KSR transmits the
signal from Raf to MEK was recently revealed in the studies of
the crystal structure of MEK bound to KSR2, a homolog of KSR1
(Brennan et al., 2011). Structural analysis and several in vitro
assays suggest that Raf interacts with KSR in cis to induce a con-
formational switch ofMEK. This switch involves phosphorylation
of MEK by KSR2 on specific sites that are distinct from the activa-
tion segment sites S218/S222. As a consequence MEK exposes its
activation segment which is now accessible for a catalytic Raf to
interact in trans (Figure 2). Similarly, the yeast scaffold Ste5 has
a domain that catalytically activates Fus3 for phosphorylation by
Ste7 (Good et al., 2009).
WHAT IS THE OPTIMAL SCAFFOLD CONCENTRATION FOR
BEST SIGNAL FIDELITY?
The capability of a scaffold to enhance signaling depends on
the scaffold’s expression level, and both theoretical and exper-
imental analyses suggest that there is a biphasic dependence
of scaffold performance on concentration, highlighted also by
numerous reviews (Yu et al., 1998; Cacace et al., 1999; Burack
FIGURE 2 | Schematic of MEK phosphorylation by the allosteric
transition of KSR induced by B-Raf binding. A KSR2-MEK side on side
dimer is formed where the activation segments are facing each other and
are thus inaccessible. A regulatory Raf interacts with KSR in cis to induce a
conformational shift of KSR2 αC helix into the active position. Due to steric
hindrance a separate catalytic Raf in trans can then phosphorylate MEK.
and Shaw, 2000; Ferrell, 2000; Levchenko et al., 2000; Heinrich
et al., 2002; Kortum and Lewis, 2004; Shao et al., 2006; Ramos,
2008; Chapman and Asthagiri, 2009; Good et al., 2011). Whereas
at lower concentrations increasing scaffold concentration facili-
tates signal transmission, a further increase beyond an optimal
level attenuates signaling. Mechanistically, a very high concentra-
tion of scaffolds would sequester binding partners in complexes
that would be incomplete. For example, a scaffold that brings
together MEK and ERK would at high expression levels form
mainly complexes with onlyMEK or only ERK, but only few com-
plexes with both MEK and ERK. This effect is generally known
as the prozone effect (Bray and Lay, 1997) and for scaffolds
has been termed “combinatorial inhibition” (Levchenko et al.,
2000). Theoretical analyses of Heinrich et al. and Levchenko et al.
predicted that the optimal scaffold concentration would be in
the same order of magnitude as the concentration of interact-
ing signaling proteins (Levchenko et al., 2000; Heinrich et al.,
2002).
Such biphasic response has been observed experimentally in
different systems. When yeast cells are engineered to express dif-
ferent levels of myc-tagged Ste5, the response of pFus3, pKss1,
and a reporter gene is biphasic (Chapman and Asthagiri, 2009).
Similarly, when varying the levels of KSR1 in MEFs (mouse
embryonic fibroblasts), an optimal level of scaffold exists at
which maximal signaling output is observed, both at the level
of ERK phosphorylation but also at the level of proliferative
and oncogenic capacity (Kortum and Lewis, 2004). While the
overall behavior is in line with mathematical models, quan-
tification of the complexes reveals somewhat surprising results:
only 5% of the kinases co-precipitate with the scaffold, whereas
models would suggest that most kinases would attach to the
scaffold. One way to explain this discrepancy is that KSR1
facilitates signaling only in a certain subcellular location, thus
effectively having only access to a small pool of the signaling
molecules.
AWIDE RANGE OF SCAFFOLD CONCENTRATIONSMAY
OPTIMALLY SUPPORT SIGNALING
Mathematical analysis so far has highlighted that there is a clear
optimum at which scaffolds enhance signaling, and even small
deviations from this optimum will lead to attenuated signaling
(Levchenko et al., 2000). Considering the natural stochasticity
and variability of gene expression (Sigal et al., 2006), it seems
unlikely that the cell depends on a strictly regulated concentra-
tion of scaffold. For this reason we revisited a previous theoretical
analysis that led to the conclusion of an optimal scaffold con-
centration. We considered a generic scaffold molecule that can
bind three kinases. Such scaffold may facilitate signaling when it
binds all three kinases at the same time, but it could attenuate sig-
naling when it binds only one or two kinases. For simplicity we
made the assumption that binding of the ligands to the scaffold
happens independently from each other. Under these assump-
tions, one can then use occupation probabilities to calculate how
many scaffolds carry complete kinase cascades and thus support
signaling (Yang and Hlavacek, 2011): when a ligand X is in a
dynamic equilibriumwith the scaffold S (see sketch in Figure 3A),
we can calculate the concentration of the scaffold-ligand
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A
B
C
FIGURE 3 | The optimal scaffold concentration range. (A) A generic
scaffold molecule with three binding sites binds to a kinase X reversibly with
the dissociation constant KD. The probability for kinase X to be bound to the
scaffold is given by the concentration of the scaffold-kinase complex SX
divided by the total amount of scaffold ST. Assuming that binding of all 3
kinases R (Raf), M (MEK), and E (ERK) is independent from the occupation of
the other binding sites, single binding probabilities can be multiplied to obtain
the probability for the situation where several kinases are bound at the same
time. (B) The model presented in (A) was used to calculate the concentration
of a full scaffold complex (all 3 kinases bound) vs. total scaffold
concentration. We consider either an equal amount of ligands (2 Raf, 2MEK,
and 2ERK, left panel) or different amounts of ligands (2 Raf, 10MEK, and
20ERK in the mid panel, 2 Raf, 100MEK, and 200ERK in the right panel) for
high (KD = 0.01 left and mid panel, KD = 0.1 right panel) and low (KD = 1 left
and mid panel, KD = 10 right panel) binding affinity. (C) Given a set of various
amounts of ligands (here 2 Raf, 5 MEK, and 10 ERK) the optimal range of
scaffolds can be explained as follows: Firstly, the least abundant ligand (Raf)
determines the maximal number of full complexes that can be formed (two).
Until an amount of scaffolds that equals the number of the second less
abundant ligand, MEK (5), every scaffold can be occupied with MEK and ERK
and so 2 out of 2 possible full complexes can be formed. Having one scaffold
molecule more than MEK molecules (6 scaffolds), one scaffold will miss MEK
and with a certain probability (p = 1/6) Raf will bind to the one that misses
MEK and in this case, only 1 out of 2 full scaffold complexes can be formed.
complex denoted as SX from the following mass-balance
equation:
dSX
dt
= kon × S × X − koff × SX
When we relate S and X to the total amounts of scaffold ST and
ligand XT and replace the ratio of koff/kon with the dissociation
constant KD, we find
(ST − SX) × (XT − SX)
SX
= KD
This can be solved for SX, as shown in Figure 3A. The occupation
probability p(X bound) is given by the ratio of the concen-
tration of the complex SX and the total scaffold concentration
ST. Because we assume that binding occurs independently, the
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probability that all three ligands are bound at the same time is
simply given by the product of the single binding probabilities as
shown in Figure 3A.
Figure 3B shows the concentration of the fully occupied scaf-
fold complex vs. the total concentration of the scaffold for dif-
ferent binding affinities of the kinases, one for a high and one
for a low (yet equal) binding affinity of all kinases. When the
concentration of the three kinases is identical, there is a sharp
optimum of scaffold concentration exactly at the level of the
ligands (Figure 3B, left panel). Interestingly, when the kinases are
available at different concentrations, there is an optimal range of
scaffold concentrations framed by the level of the least frequent
and the 2nd less abundant kinase (Figure 3B, middle panel).
In mammalian cells, kinases in the MAPK signal transduction
pathways are present in very different concentrations, as Raf is
typically present in a very low concentration (∼13 nM in HeLa
cells), (Fujioka et al., 2006) while MEK and ERK are rather
present at concentrations of about 1μM(also in HeLa cells) (Aoki
et al., 2011), thus the concentration ratio of Raf and MEK is at
around 1:100. Given this difference in ligand concentration, a 100
fold change in scaffold expression would not change its ability to
optimally support signaling, which is illustrated in the right panel
of Figure 3B. In line with this model, single cell measurements of
ERK phosphorylation in Jurkat cells have confirmed that activa-
tion of ERKwas unchanged until 100 fold overexpression of KSR1
(Lin et al., 2009). Surprisingly, a recent quantification of the pro-
teome of HeLa cells unveiled that KSR1 is expressed with 1800
copies per cell, which is about 3-fold lower than the expression of
Raf and more than an order of magnitude lower than the expres-
sion of MEK or ERK in these cells (Nagaraj et al., 2011). This
suggests that KSR1 may have an regulatory impact in these cells,
as we predict that upregulation of KSR1 will enhance signaling.
AN INTUITIVE EXPLANATION FOR AN OPTIMAL SCAFFOLD
RANGE
There is a straightforward and very intuitive explanation for the
results of the mathematical treatment. Consider a set of 2 Raf,
5MEK, and 10 ERK molecules (as shown in Figure 3C) that bind
to a scaffold very tightly with a very low dissociation constant
(∼0), the model predicts an optimal scaffold number between
2 and 5. This is because firstly, the least abundant component,
which is Raf in this example, determines the maximal number of
full complexes. At least the same number of scaffold molecules
has to be available to actually form the maximum number of
full complexes (2). When the number of scaffold molecules is
in accordance with the level of MEK (5), every scaffold can be
occupied by MEK. Also, every scaffold can bind ERK as this com-
ponent is in excess. The 2 Raf molecules will bind to two arbitrary
scaffold molecules and thus the optimum number of full scaf-
folds is reached (see Figure 3C). However, when the number of
scaffolds starts to exceed the level of MEK by one molecule, one
Raf molecule may either bind to the scaffold containingMEK and
ERK or to the scaffold that misses MEK (Figure 3C). In the latter
case only one fully occupied scaffold will be formed. That is why
the concentration of a full scaffold decreases when the scaffold
concentration exceeds the level of MEK. The exact position of the
optimal scaffold concentration range depends on the dissociation
constant of the single kinases. With higher dissociation rates the
chance for a kinase to be bound to the scaffold decreases and thus
the optimal scaffold concentration range is curtailed (compare
the curves for high and low dissociation rates in Figure 3B).
THE ASSEMBLY OF SCAFFOLDING COMPLEXES IS HIGHLY
DYNAMIC
The function of scaffolds critically depends on tight binding of
the pathway kinases. However, not all MAPK components have
the same affinity. The interaction of KSR1 and MEK has even
been shown to be constitutive (Denouel-Galy et al., 1998; Stewart
et al., 1999). Tightly bound kinases are restricted in their diffusion
away from the protein complex which limits their turnover and
spatial redistribution, thus signal amplification might be reduced
(Good et al., 2011). Contrary the terminal kinase would have to
be bound rather loosely to explore targets within the cytoplasm
and the nucleus after its activation. A solution to the paradox is a
dynamic regulation of the binding affinity of the terminal kinase
to the scaffold. A prototype example for such substrate release is
the MAPK Fus3, which has been shown to bind relatively weakly
to Ste5 and is easily released allowing signal amplification and
also translocation to the nucleus (Good et al., 2009). The release
of Fus3 is promoted by the dephosphorylation of several dis-
tinct sites at Ste5 by the pheromone-induced phosphatase Ptc1.
Dephosphorylation of these sites decreases the binding affin-
ity of the Ste5-Fus3 complex, allowing release of activated Fus3
(Malleshaiah et al., 2010). In accordance, Bhattacharyya et al.
found that when replacing wild type Ste5 with a Ste5 mutant
of impaired Fus3 docking, expression of a Fus1-GFP reporter
increased 2-fold (Bhattacharyya et al., 2006). The authors con-
clude that the normal function of Ste5-Fus3 docking might even
be to attenuate signaling to some degree.
Also, the ternary interaction of the scaffold KSR1 with B-Raf
and MEK is highly dynamic. Stimulation of cells with EGF loads
B-Raf to the scaffold, also ERK is localized to this complex and
phosphorylated thereafter. When docking of ERK is impaired by
a mutation, the KSR1-MEK-B-Raf complex persists even 20min
after stimulation, where otherwise, almost all B-Raf has left
the complex at this time. However, even when ERK-docking is
impaired, it is still phosphorylated. Both KSR1 and B-Raf are
feedback phosphorylation targets of ERK and these feedbacks are
enhanced by docking of ERK (McKay et al., 2009). This feed-
back phosphorylation seems to be related to the dissociation of
the signaling complex, as ERK-mediated feedback phosphoryla-
tion is shown to prevent sustained ERK signaling (Canal et al.,
2011).
SCAFFOLDS MIGHT IMPOSE STOICHIOMETRIC
RESTRICTIONS
The experimental studies that we have discussed so far sum-
marize how scaffolds enhance signaling. A recent theoretical
study highlights that scaffolds can have dual effects on signal-
ing: Either they support or they attenuate signaling depending
on the level of the generic phosphatases as shown in Figure 4A
(Locasale et al., 2007). When kinases activate each other in
solution, one kinase can activate multiple targets and thus the
signal can spread exponentially along the cascade [case (i) in
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A B
FIGURE 4 | Proposed effects for the action of scaffolds. (A) Schematic for
high and low phosphatase activity with and without scaffold. (i) When there is
low phosphatase activity and no scaffold present, the kinases can readily
activate each other and the signal spreads exponentially along the cascade.
(ii) When kinases are bound to scaffold under low phosphatase activity, each
kinase is localized so it is only likely to interact with their neighboring
substrate kinase and signal amplification is attenuated. (iii) When the level of
phosphatase activity is high and there is no scaffold for kinases to complex
with, the propogation of the signal is impeded as the kinase will likely
encounter a phosphatase and become deactivated before it meets its
downstream target. (iv) Under conditions of high phosphatase activity, the
scaffold complex facilitates signal amplification due to the enhanced local
concentration of kinases. This is because the likelihood for a kinase to
successfully interact with its substrate kinase is much higher than for the
encounter with a deactivating phosphatase which is not localized to the
scaffold. Gray squares represent phosphatases. (B) Trans activation of
incomplete scaffold complexes. Kinases bound to different partially occupied
scaffolds may activate each other in trans.
Figure 4A]. However, when loaded on a scaffold, each kinase can
only interact with the neighboring substrate kinase, which pre-
vents strong signal amplification [case (ii) in Figure 4A]. This
mechanism is termed stoichiometric inhibition, as the interact-
ing kinases are coupled in a 1:1 ratio when they are bound to
a scaffold (Locasale et al., 2007). However, when the level of
phosphatases is high, the enhanced local concentrations will lead
to signal amplification, as the chance for a successful encounter
of the kinase with its downstream kinase is much higher than
for the encounter with the deactivating phosphatase which is
not localized to the scaffold [case (iv) in Figure 4A]. Thus, scaf-
folds may provide a mechanism to somehow isolate signaling
pathways from changing levels of generic phosphatases: a sig-
naling pathway that consists of freely diffusing kinases may be
strongly attenuated when phosphatases are upregulated [case (iii)
in Figure 4A], while signaling on scaffolds may be only weakly
effected. Cells may utilize this mechanism to vary amplification
at some signaling pathways in different contexts or cell types,
whereas amplification for those on scaffolds remain unaffected.
SIGNALING SPECIFICITY THROUGH SCAFFOLDS
The main task of the signaling network is to reliably transduce
information and ultimately lead to an appropriate response after
receiving a certain stimulus. Thus, robust signaling is important
in the sense that the signal does not spread over the entire net-
work, but rather remains confined to the pathways that trigger
the desired response to the signal. Signaling pathways often share
components such as MAP3Ks, MAP2Ks and adapter molecules,
or signal via different isoforms that have high sequence simi-
larity, which for example interact via very similar binding sites.
Thus, signals may leak to pathways with other function, leading
to undesired crosstalk. Alongside mechanisms of mutual pathway
inhibition e.g., by feedback regulation (Nakakuki et al., 2010), and
compartmentalization, scaffolds are thought to play a major role
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in conferring signaling specificity to pathways (Bardwell et al.,
2007).
Mechanistically, signal specificity may be realized by tethering
components to a scaffold by which the components are physically
isolated from becoming involved with other pathways (Levchenko
et al., 2000). However, such isolationmay onlywork when the rate
of deactivation exceeds the rate at which the component moves
on and off the scaffold, as otherwise the kinases may move on
to different locations, and signaling specificity is lost (Bardwell
et al., 2007). How scaffolds confer signal specificity to MAPK
signaling is best understood in yeast, where various signaling
pathways use joint components (see Figure 5). For example, the
mating response, the osmotic stress response as well as the inva-
sive growth response are all transmitted via the activation of the
kinase Ste11, a MAP3K. However, the different MAPKs further
downstream are selectively activated depending on the stimulus.
In osmotic stress signaling, specificity supposedly is achieved by
receptor specific recruitment and activation of Pbs2, which is not
only a scaffold but also a MAP2K of the pathway at the same
time (O’Rourke et al., 2002), which leads to selective activation
of Hog1. The mating pathway and the pathway triggering fila-
mentous growth share two kinases: Ste11, a MAP3K and Ste7,
a MAP2K. The interplay of various mechanisms allows yeast
cells to distinguish between these two conflictive signals: Kss1,
the MAPK involved in the invasive growth response, is activated
under both conditions, and possibly requires no scaffold. In con-
trast, Fus3 is only highly activated when the mating pathway is
triggered. Mechanistically, strong activation of Fus3 requires the
scaffold Ste5, which binds Fus3 with a higher affinity than Kss1
(Choi et al., 1994; Kusari et al., 2004). When binding to Fus3,
Ste5 catalytically activates Fus3 for phosphorylation by Ste7 by
selectively increasing the kcat for this process (Good et al., 2009).
Furthermore, Ste5 itself is thought to be in a closed conformation
without pheromone stimulation. In that sense, activation of Fus3
can be understood as a mating-specific phenomenon that is estab-
lished by selective activation of the scaffold Ste5. Bardwell et al.
describe this mechanism of signaling specificity as a logical AND-
gate, since it requires activation of Ste5 and the Fus3 (Bardwell,
2006). However, the scaffold obviously cannot prevent accidental
activation of Kss1 during the mating response, so that additional
mechanisms are required. Although Kss1 is somewhat activated
by mating signals, target genes of Kss1 which are typical for the
invasive growth response, remain silent. At least two negative
paths from Fus3 to Kss1 have been reported and they might act to
suppress the Kss1 response when Fus3 is activated, termed cross-
pathway inhibition. Thus, in this case, the scaffold generates some
signaling specificity, yet downstream cross-talks and feedbacks act
to further increase the specificity.
Also in mammalian cells the involvement of different scaf-
folds can control the dynamics and cellular outcome when the
same pathway is activated. For example, when ERK activation is
initiated at the cell membrane it is transient and ERK has the
ability to translocate to the nucleus. However, the MAPK cas-
cade sequestered at the endosome by the presence of β-arrestin
is characterized by sustained activation, leading potentially to the
stabilization of transcription factors such as FOSL1 (Nakakuki
et al., 2010) and the expression of different genes and more
localized ERK activation in the cytoplasm (Kholodenko et al.,
2010).
KSRs IN MAMMALIAN CELLS: SCAFFOLDS THAT CAN
ROUTE SIGNALS TO DIFFERENT SUBCELLULAR LOCATIONS
Also in mammalian cells, the MAPK pathway via the terminal
kinase ERK triggers various and often opposing cellular out-
comes, which include proliferation, apotosis, migration, and cell
differentiation. It is however less well-understood how scaffolds
Msb2 Sho1 Sho1
Msb1
Hkr1
A B C
FIGURE 5 | Scaffold proteins and specificity in the yeast MAPK
pathway. The mating response (A), filamentous growth response (B), and
osmotic stress response (C) pathways all share the MAP3K Ste11. In the
osmotic stress response, Pbs2 acts as a scaffold and also a MAP2K of
the pathway at the same time. The mating response and filamentous
growth pathways both share MAP2K Ste11 and MAP3K Ste7. Specificity
occurs through the scaffold Ste5, which is required for the activation of
Fus3 during the mating response. However there may be accidental
activation of Kss1 during the mating response and further specification
can be achieved by a negative feedback. The filamentous growth pathway
possibly does not require a scaffold. Signal flow is shown by black arrows
and red T shaped bar indicates inhibition.
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contribute to signal specificity, but it is believed that one mech-
anism is that the interaction of kinases with the large number
of different scaffold proteins somewhat determines specificity by
targeting the kinases to certain regions of the cell (see Table 1),
and by differential expression in different tissues (see Figure 6),
the outcome of MAPK signaling might differ strongly. Thus, scaf-
folds do not only provide a platform on which signaling can
happen, but also have been shown to regulate the spatial and
temporal signaling of MAPK by directing the signal to specific
subcellular compartments (Brown and Sacks, 2009). For exam-
ple, β-arrestin 2 mainly directs ERK1/2 to the clathrin coated pits
(Shenoy and Lefkowitz, 2003) and Sef captures activated ERK at
the Golgi preventing nuclear translocation but allowing phospho-
rylation of substrates in the cytoplasm (Torii et al., 2004). Another
example is KSR1 that can translocate dynamically: In resting cells,
KSR1 is sequestered by the cytoplasm. Upon stimulation KSR1
translocates to the membrane of the cell to facilitate MAPK sig-
naling, by bringingMEK in close contact to its kinase Raf (Müller
et al., 2003). In the brain, where KSR1 is highly expressed, feed-
back phosphorylation of ERK1/2 regulates the distribution of
KSR1 in the post-synaptic compartment of hippocampal neu-
rons and thusmodulates its synaptic plasticity (Canal et al., 2011).
When there is little ERK1/2 activity then KSR1 is concentrated in
the dendritic spines. With neuronal activity there is a consequen-
tial increase in ERK1/2 activation and KSR translocates to the
dendrite as a result of feedback phosphorylation which regulates
the signaling output of MAPK. Importantly, a feedback impaired
variant of KSR1 shows that ERK-mediated feedback phosphory-
lation of KSR1 prevents sustained ERK signaling in neurons and
thus may contribute to signaling homeostasis and also to home-
ostasis of synapses (Canal et al., 2011). KSR preferentially acts on
MAPK signals originating from cholesterol rich domains of the
plasma membrane that further highlights their spatial regulation
of ERK signals (Matheny et al., 2004).
KSR1 can also route signals to the cytoplasm: in addition to
binding Raf and MEK, KSR1 (but also other scaffolds such as Sef
and IQGAP1) helps to assemble ERK1/2 dimers that are essen-
tial for interaction of ERK with cytoplasmic substrates (Casar
et al., 2008). For example, large amounts of cPLA2, a cytoplas-
mic substrate of ERK1/2, were associated to KSR1 following EGF
stimulation. As simultaneous binding of cPLA2 and the scaffold
to ERK2 would be sterically unlikely and since ERK is known to
homodimerize upon activation, the current model is that ERK
dimers are formed where one molecule of ERK2 is bound to
cPLA2 whilst the other is bound to KSR1. The dimerization
mechanism occurs when a phosphorylated ERKmonomer bound
to scaffold interacts with a free phospho-ERK monomer that
has probably been released from a MEK-ERK complex. These
dimers specifically phosphorylate ERK substrates in the cyto-
plasm. Alternative routes for the phosphorylated ERK monomers
FIGURE 6 | Tissue-specificity of gene expression. Gene expression of
scaffolds varies strongly between tissue types and each tissue has a
specific pattern of expressed scaffolds. Expression was averaged
across all samples, and log2-changes from this average are shown in
the heatmap, with red indicating high expression and blue low
expression. Data were obtained from the GNF mouse gene atlas
V3, GEO accession number GSE10246, normalized using rma with
standard parameters.
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have been suggested including translocation to the nucleus to
phosphorylate transcription factors or dimerizing freely in the
cytoplasm and then moving to the nucleus as Casar et al. also
found a few ERK dimers in the nucleus following activation
(Casar et al., 2008). Therefore, KSR1 can control whether sub-
strates in the nucleus or cytoplasm are activated. The roles of
scaffolds such as KSR1may be very different in different cell types,
and the cell-type and tissue-specific expression of scaffolds may
play an important role to attribute different functions to MAPK
signaling in different tissues (see Figure 6).
SCAFFOLDS AND ULTRASENSITIVITY
Cellular decision-making involves the ability to respond to a con-
tinuously variable stimulus with a defined answer, either yes or
no. Famous all or none switches (biological responses) are the
Xenopus oocyte maturation in response to progesterone (Ferrell
and Machleder, 1998) or shmooing of yeast cells in response
to a/α-factor (Paliwal et al., 2007; Malleshaiah et al., 2010).
The reason for switch-like behavior may be a steep stimulus-
response profile, described as ultrasensitivity, but it might also
be bistability where the system switches from one stable steady
state to another. Ultrasensitive responses are beneficial since they
allow to filter out noise and to respond vigorously to appro-
priate stimuli. Supposedly, ultrasensitive responses are generated
by mechanisms that are embedded in the signaling network
structure and might be visible already at the level of the respec-
tive MAPK. For example, the response of JNK is ultrasensi-
tive when stimulating either HeLa, HEK 293, or Jurkat T Cells
with sorbitol or anisomycin (Bagowski et al., 2003). In general,
multistep processes of (de)activation can generate robust ultra-
sensitive responses (Deshaies and Ferrell, 2001; Blüthgen and
Herzel, 2003; Salazar and Höfer, 2009). Examples are the activa-
tion of a kinase by several consecutive phosphorylation events,
but also saturation of an enzyme by stepwise binding of lig-
ands with positive cooperativity. Positive feedbacks can create
bistability, however it was shown that a system with distributive
multisite (de)phosphorylation does not need additional regula-
tory layers for bistability to exist (Markevich et al., 2004). With the
perception of scaffolding molecules as a vital part of MAPK sig-
naling cascades, several experimental and theoretical studies have
focused on the question whether scaffolds contribute positively or
negatively to ultrasensitivity.
In theory, the three-tiered MAPK cascade comprising sin-
gle phosphorylation of Raf and dual phosphorylation of MEK
and ERK, is inherently ultrasensitive (Huang and Ferrell, 1996)
and a critical determinant of this property is the assumed dis-
tributive mechanism of (de)phosphorylation. Levchenko et al.
studied the effect of a generic scaffold molecule that sequesters a
substrate and its kinase and assumed that the scaffold would con-
tribute to processive phosphorylation (Levchenko et al., 2000).
This assumption dates back to an experimental study, where a
so far unidentified protein enhanced dual phosphorylation of
ERK by MEK (Scott et al., 1995). Processive rather than dis-
tributive phosphorylation would then counteract ultrasensitivity.
Not surprisingly, the model predicts that the stimulus-response
relationship of the cascade becomes more graded at increas-
ing levels of supporting scaffold. However, to date experimental
proof is still lacking that would support the function of scaffolds
to promote processive phosphorylation. The dynamics of ERK
phosphorylation in EGF-stimulated HeLa cells is in accordance
with processive phosphorylation, but a knockdown of either KSR,
MP-1, IQGAP1, Paxillin, or β-arrestin 1/2 did not change proces-
sivity but only the ERK phosphorylation efficiency (Aoki et al.,
2011). Another theoretical study highlights that even when rapid
enzyme-substrate rebinding is possible the necessity of exchang-
ing ADP for ATP on the kinase might preclude this opportunity
for quasi-processive phosphorylation (Takahashi et al., 2010).
In general, a gradual progress of morphological changes can be
observed when yeast cells are stimulated with increasing amounts
of pheromone (Paliwal et al., 2007). In accordance with these
gradual changes in phenotype, is the gradual expression of a Fus1-
GFP reporter in response to pheromone which was observed in
single yeast cells (Poritz et al., 2001). The graded response profile
is neither established by the action of negative feedback regu-
lators, nor by the sole presence of the scaffold Ste5 (Takahashi
and Pryciak, 2008). Once signaling to Fus3 is decoupled from
Ste5 membrane translocation by direct constitutive activation of
Ste11, signaling becomes ultrasensitive. This confirms a switch-
like behavior of the isolated MAP3K-MAP2K-MAPK module,
even in the presence of a scaffold and suggests that the graded
response is due to Ste5 membrane localization upon pathway
stimulation. Also here it is speculated that the common view of
a fully occupied scaffold, in which all bound kinases influence
each other in a beneficial way, i.e., by allowing processive activa-
tion, might be wrong. Ultimately, the graded response might be a
result of the close proximity of differently occupied scaffolds due
to membrane localization. The kinases that sit on different scaf-
folds then can activate each other in trans (Takahashi and Pryciak,
2008) (see Figure 4B). Interestingly, a theoretical model confirms
that at constitutive Ste11 activity (in the absence of pheromone
stimulation) an increased ultrasensitivity can only be explained
by trans-activation of kinases that are located on different scaf-
folds and whose interactions are characterized by weak affinities
(Thalhauser and Komarova, 2010).
Despite the gradual morphological changes of yeast in
response to increasing levels of pheromone, the final decision
to form a shmoo is switch-like. In an experimental analysis the
average response of a population of yeast cells on the level of
Fus3 appeared to be slightly ultrasensitive with a Hill coeffi-
cient nH ∼2.2 (Hao et al., 2008). A mathematical model of the
pheromone response can reproduce this Hill coefficient, how-
ever, the model suggests that ultrasensitivity of the response
is generated at a level upstream from Ste5-scaffolded signaling
(Thalhauser and Komarova, 2010). In more detail, the model
incorporates a dual influence of pathway activation as it contains a
stimulus-dependent rate of proper Ste7-alignment (bymembrane
localization) and a stimulus-dependent rate of Ste11-activation.
Increasing either the rate of membrane-binding or the rate of
Ste7-alignment, the system response can be tuned to become
more graded (Thalhauser and Komarova, 2010).
In contrast, Malleshaiah et al. attribute an active role to
the scaffold in producing the all-or-none shmoo response
(Malleshaiah et al., 2010), as the dissociation of the Ste5-
Fus3 complex in response to pheromone stimulation is highly
ultrasensitive. Strikingly, the response of a Fus3-docking impaired
Ste5 mutant becomes graded. At the basis of the steep response
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is a competition of the alpha-factor-induced phosphatase Ptc1
with Fus3 for access to several distinct phosphorylation sites on
the scaffold. Progressive dephosphorylation of these sites nega-
tively influences the binding affinity of the Ste5-Fus3 complex
(Malleshaiah et al., 2010).
Graded stimulus-response profiles are frequently observed in
mammalian cells (Whitehurst et al., 2004; MacKeigan et al.,
2005; Tian et al., 2007). However, experimental data also sug-
gest that the properties of the signal-response profile are not
determined on the level of the scaffold. For example, single
cell measurements of ERK phosphorylation in Jurkat cells show
that the MAPK pathway may either show a graded response to
chemokine SDF-1 stimulation or a digital response when the
T-cell receptor is involved. The response pattern of both path-
ways is not influenced by the expression level of KSR1 (Lin
et al., 2009). In baby hamster kidney cells the response to EGF
appears graded. EGF-signaling is initiated at Ras-GTP nano-
clusters that consist of roughly 7 Ras-GTP molecules with a
lifetime of about 0.4 s and which recruit Raf to the membrane.
Each nano-cluster is shown to act as a molecular switch, that
converts a graded input to an all or none response (Tian et al.,
2007). However, as the amount of clusters is increasing linearly
with the stimulus, the integrated response over all clusters is
graded, yielding a linear response of ERK phosphorylation to EGF
stimulation.
In summary, contrary to previous reports switch-like
responses seem to be possible even in the presence of a scaf-
fold molecule (Levchenko et al., 2000). A theoretical study even
finds that the presence of a scaffold can increase the likelihood of
bistability to occur, especially when the affinity of substrate and
modifying enzyme is low. Parameter sets that support bistability
are characterized by a limiting concentration of scaffold com-
pared to the level of substrate that is modified on the scaffold
and a scaffold-substrate dissociation constant that varies with
substrate phosphorylation state (Chan et al., 2012). On the other
hand, when the response of a pathway is graded, this is not neces-
sarily due to the presence of a scaffold, but may be due to strong
negative feedbacks that are known to determine the pathway’s
behavior (Sauro and Kholodenko, 2004; Cirit et al., 2010; Sturm
et al., 2010; Fritsche-Guenther et al., 2011), or under some situ-
ations ultrasensitivity might be enhanced by positive feedbacks
(Santos et al., 2007).
To date, the discussion about stimulus-response profiles suf-
fers from ambiguities that result from measurement of responses
at different levels (MAPK, MAPK-target-reporter gene, morpho-
logical response), evaluation of the response in different ways
(integrated response or response at a certain time after stim-
ulation) and evaluation of the response at the single cell or
population level. Ultrasensitivity at the single-cell response pro-
file is potentially lost when averaging over a population of cells.
For example, the response of JNK to progesterone in Xenopus
oocytes is ultrasensitive at the single cell level. However, as the
critical concentration for a switch to occur varies greatly between
single oocytes, the JNK response of a population of cells appears
to be graded (Bagowski and Ferrell, 2001). Thus, the precise role
of scaffolds on changing the ultrasensitivity of stimulus response
has yet to be established.
CONCLUSIONS
While more and more mechanistic details about the action of
scaffolds emerge, the role for scaffolds on the dynamics of MAPK
signaling is currently not well-established for mammalian cells.
Although many recent studies show how KSR1 controls spa-
tial routing of signals and facilitates signal initiation, we still
lack a comprehensive understanding of the role of the scaffold.
Detailed mechanistic mathematical modeling and quantitative
experimentation has been useful in the past by shedding light
on how signaling works dynamically. For the yeast scaffold Ste5,
mathematical models to explore the action of the scaffold have
come to some maturity and provide detailed understanding of
the role of this scaffold in this pathway. Similarly, we think that
it would be timely to quantitatively study the role of KSR1 on
signaling dynamics in mammalian cells, with detailed quanti-
tative experiments that estimate the concentrations of scaffolds
and signaling molecules. While the rather abstract models of
scaffolds in mammalian MAPK signaling were helpful to con-
ceptualize how scaffolds act, they also led to misleading results:
The commonly accepted notion of the presence of an optimal
scaffold concentration has led to the conclusion that scaffolded
signaling might be more sensitive to perturbations in the con-
centration of pathway components (Ferrell, 2000). However, for
this conclusion the details matter, and the behavior changes when
simulating a scaffold model with realistic concentrations for sig-
naling molecules. Since the ligands of the scaffold show different
expression levels, a large range of scaffold concentrations may
optimally support signaling.
Working toward realistic models for scaffolds is challenging
due to combinatorial explosion: a comprehensive model of signal-
ing via Ste5 which involves all 27 possible scaffold configurations
both in cytoplasm and when located to the membrane exempli-
fies this complexity (Shao et al., 2006). Taking into account the
oligomerization of Ste5 the number of signaling complexes would
increase to 27 × 27 = 729. Thus, simpifying assumptions will be
needed to develop these models and parameterize them.
Differential expression of scaffolds in different cell types may
be one of the main reasons why many cell-type-specific inter-
actions and feedbacks exist. Hence, once we know more about
how scaffolds shape signal transduction, we will most likely also
understand how and why MAPK signaling gains different roles
in different tissues. Again, one can learn from yeast, where the
scaffold protein Ste5 has been modified using a synthetic biology
approach to recruit molecules that are either positive or negative
regulators. These regulators are either induced by the pathway or
expressed constitutively, either alone or in combination, which
affects the shape of the pathway response in a predictable manner.
This study highlights not only a chance for potential therapeutic
results by targeted engineering of a pathway but also documents
the various functions a scaffold might bear within the cell (Bashor
et al., 2008).
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